首页 | 本学科首页   官方微博 | 高级检索  
检索        


Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population
Authors:M Chan  S M Ji  C S Liaw  Y S Yap  H Y Law  C S Yoon  C Y Wong  W S Yong  N S Wong  R Ng  K W Ong  P Madhukumar  C L Oey  P H Tan  H H Li  P Ang  G H Ho  A S G Lee
Institution:1. Division of Medical Sciences, National Cancer Centre, Singapore, 11 Hospital Drive, Singapore, 169610, Republic of Singapore
2. Department of Medical Oncology, National Cancer Centre, Singapore, Singapore, Republic of Singapore
3. DNA Diagnostic and Research Lab, KK Women??s & Children??s Hospital, Singapore, Republic of Singapore
4. Department of General Surgery, Singapore General Hospital, Singapore, Republic of Singapore
5. Department of Surgical Oncology, National Cancer Centre, Singapore, Singapore, Republic of Singapore
6. Department of Pathology, Singapore General Hospital, Singapore, Republic of Singapore
7. Department of Clinical Research, Singapore General Hospital, Singapore, Republic of Singapore
8. Oncocare Cancer Centre, Gleneagles Medical Centre, Singapore, Republic of Singapore
Abstract:Genome-wide association studies (GWAS) have identified various genetic susceptibility loci for breast cancer based mainly on European-ancestry populations. Differing linkage disequilibrium patterns exist between European and Asian populations, and thus GWAS-identified single nucleotide polymorphisms (SNPs) in one population may not be of significance in another population. In order to explore the role of breast cancer susceptibility variants in a Chinese population of Southern Chinese descent, we analyzed 22 SNPs for 1,191 breast cancer cases and 1,534 female controls. Associations between the SNPs and clinicopathological features were also investigated. In addition, we evaluated the combined effects of associated SNPs by constructing risk models. Eight SNPs were associated with an elevated breast cancer risk. Rs2046210/6q25.1 increased breast cancer risk via an additive model per-allele odds ratio (OR)?=?1.43, 95?% confidence interval (CI)?=?1.26?C1.62], and was associated with estrogen receptor (ER)-positive (per-allele OR?=?1.39, 95?% CI?=?1.20?C1.61) and ER-negative (per-allele OR?=?1.55, 95?% CI?=?1.28?C1.89) disease. Rs2046210 was also associated with stage 1, stage 2, and stage 3 disease, with per-allele ORs of 1.38 (1.14?C1.68), 1.48 (1.25?C1.74), and 1.58 (1.28?C1.94), respectively. Four SNPs mapped to 10q26.13/FGFR2 were associated with increased breast cancer risk via an additive model with per-allelic risks (95?% CI) of 1.26 (1.12?C1.43) at rs1219648, 1.22 (1.07?C1.38) at rs2981582, 1.21 (1.07?C1.36) at rs2981579, and 1.18 (1.04?C1.35) at rs11200014. Variants of rs7696175/TLR1, TLR6, rs13281615/8q24, and rs16886165/MAP3K1 were also associated with increased breast cancer risk, with per-allele ORs (95?% CI) of 1.16 (1.00?C1.34), 1.15 (1.02?C1.29), and 1.15 (1.01?C1.29), respectively. Five SNPs associated with breast cancer risk predominantly among ER-positive tumors (rs2981582/FGFR2, rs4415084/MRPS30, rs1219648/FGFR2, rs2981579/FGFR2, and rs11200014/FGFR2). Among our Chinese population, the risk of developing breast cancer increased by 90?% for those with a combination of 6 or more risk alleles, compared to patients with ??3 risk alleles.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号